Loading company…
Smart Tissues develops bioprinted bioinks and wound-healing materials for chronic wound care.
Founded in 2022 and based in Kyoto, Japan, Smart Tissues develops biocompatible bioinks and regenerative solutions for chronic wounds, including diabetic foot ulcers. Its materials are used to create wound-healing membranes through bioprinting. The company raised USD 155,000 from Antler on December 22, 2025, to develop products and expand into markets in Europe and Asia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in